Prime Medicine
PRME
PRME
115 hedge funds and large institutions have $467M invested in Prime Medicine in 2024 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 39 increasing their positions, 35 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
115
Holders Change
+10
Holders Change %
+9.52%
% of All Funds
1.67%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
23
Increased
39
Reduced
35
Closed
13
Calls
$407K
Puts
$489K
Net Calls
-$82K
Net Calls Change
+$101K
Top Buyers
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$1.58M |
| 2 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$1.08M |
| 3 |
NAMA
Nikko Asset Management Americas
New York
|
-$1.08M |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$1.06M |
| 5 |
Walleye Capital
New York
|
-$405K |
